{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:29:42Z","timestamp":1770830982974,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T00:00:00Z","timestamp":1566604800000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Project for Cancer Research","award":["17ck0106280h0001"],"award-info":[{"award-number":["17ck0106280h0001"]}]},{"name":"Project for Cancer Research","award":["17ck0106295h0001"],"award-info":[{"award-number":["17ck0106295h0001"]}]},{"name":"P-CREATE","award":["17cm0106403h0002"],"award-info":[{"award-number":["17cm0106403h0002"]}]},{"DOI":"10.13039\/501100003382","name":"CREST","doi-asserted-by":"publisher","award":["17gm0710013h0304"],"award-info":[{"award-number":["17gm0710013h0304"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003382","name":"CREST","doi-asserted-by":"publisher","award":["17gm0710010h0104"],"award-info":[{"award-number":["17gm0710010h0104"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.pan.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T21:17:21Z","timestamp":1529356641000},"page":"624-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Hirokazu","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2018.06.003_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/1471-2407-12-609","article-title":"Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis","volume":"12","author":"Mayahara","year":"2012","journal-title":"BMC Canc"},{"key":"10.1016\/j.pan.2018.06.003_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.2004.10.112","article-title":"Phase iii trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer","volume":"22","author":"Van Cutsem","year":"2004","journal-title":"J\u00a0Clin Oncol Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.pan.2018.06.003_bib5","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.2004.12.082","article-title":"Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate","volume":"22","author":"Rocha Lima","year":"2004","journal-title":"J\u00a0Clin Oncol Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.pan.2018.06.003_bib6","first-page":"364","article-title":"Folfirinox versus gemcitabine for metastatic pancreatic cancer","volume":"2011","author":"Conroy","year":"1817","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2018.06.003_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnci\/80.10.751","article-title":"Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal tumor study group","volume":"80","year":"1988","journal-title":"J\u00a0Natl Cancer Inst (Bethesda)"},{"key":"10.1016\/j.pan.2018.06.003_bib8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/annonc\/mdn281","volume":"19","author":"Chauffert","year":"2008","journal-title":"Ann Oncol Offic. J. Euro. Soc. Medical Oncol. ESMO"},{"key":"10.1016\/j.pan.2018.06.003_bib9","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial","volume":"29","author":"Loehrer","year":"2011","journal-title":"J\u00a0Clin Oncol Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.pan.2018.06.003_bib10","first-page":"62","article-title":"Cloning and chromosomal localization of the human cytoskeletal alpha-actinin gene reveals linkage to the beta-spectrin gene","volume":"47","author":"Youssoufian","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pan.2018.06.003_bib11","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1016\/S0021-9258(19)50420-3","article-title":"Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11","volume":"267","author":"Beggs","year":"1992","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pan.2018.06.003_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1083\/jcb.140.6.1383","article-title":"Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion","volume":"140","author":"Honda","year":"1998","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.pan.2018.06.003_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cm.20007","article-title":"Alpha-actinin revisited: a fresh look at an old player","volume":"58","author":"Otey","year":"2004","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.pan.2018.06.003_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/bjc.2014.623","article-title":"Actn4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer","volume":"112","author":"Watanabe","year":"2015","journal-title":"BJC (Br J Cancer)"},{"key":"10.1016\/j.pan.2018.06.003_bib15","first-page":"164","article-title":"Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial","volume":"32","author":"Hazel","year":"1981","journal-title":"J\u00a0Can Assoc Radiol"},{"key":"10.1016\/j.pan.2018.06.003_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.1985.3.3.373","article-title":"Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil\u2013an eastern cooperative oncology group study","volume":"3","author":"Klaassen","year":"1985","journal-title":"J\u00a0Clin Oncol Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.pan.2018.06.003_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A\u00a0randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2018.06.003_bib18","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjc.6603719","article-title":"Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation\/combined modality therapy","volume":"96","author":"Sultana","year":"2007","journal-title":"BJC (Br J Cancer)"},{"key":"10.1016\/j.pan.2018.06.003_bib19","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1200\/JCO.2008.19.7921","article-title":"Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review","volume":"27","author":"Huguet","year":"2009","journal-title":"J\u00a0Clin Oncol Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.pan.2018.06.003_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.2006.07.5663","article-title":"Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in gercor phase ii and iii studies","volume":"25","author":"Huguet","year":"2007","journal-title":"J\u00a0Clin Oncol Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.pan.2018.06.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2011.04.045","article-title":"Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer","volume":"81","author":"Mahadevan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pan.2018.06.003_bib23","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the lap07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"J\u00a0Am Med Assoc JAMA, J Am Med Assoc"},{"key":"10.1016\/j.pan.2018.06.003_bib24","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1158\/0008-5472.CAN-05-0718","article-title":"E-cadherin regulates the association between beta-catenin and actinin-4","volume":"65","author":"Hayashida","year":"2005","journal-title":"Canc Res"},{"key":"10.1016\/j.pan.2018.06.003_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1179::AID-CNCR3>3.0.CO;2-5","article-title":"Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis","volume":"78","author":"Ono","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2018.06.003_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9440(10)65575-7","article-title":"Inactivation of the e-cadherin-mediated cell adhesion system in human cancers","volume":"153","author":"Hirohashi","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pan.2018.06.003_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1349-7006.2003.tb01485.x","article-title":"Cell adhesion system and human cancer morphogenesis","volume":"94","author":"Hirohashi","year":"2003","journal-title":"Canc Sci"},{"key":"10.1016\/j.pan.2018.06.003_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.012425299","article-title":"Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates e-cadherin and promotes metastasis","volume":"99","author":"Ino","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pan.2018.06.003_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2004.10.004","article-title":"Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer","volume":"128","author":"Honda","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2018.06.003_bib30","first-page":"5348","article-title":"Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas","volume":"14","author":"Kikuchi","year":"2008","journal-title":"Clin Canc Res Offici J. Am. Assoc.Cancer Res."},{"key":"10.1016\/j.pan.2018.06.003_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/MPA.0b013e3181b28d6f","article-title":"Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma","volume":"38","author":"Welsch","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.06.003_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijom.2009.10.003","article-title":"Rnai-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma","volume":"39","author":"Yamada","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.pan.2018.06.003_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cam4.214","article-title":"Copy number increase of actn4 is a prognostic indicator in salivary gland carcinoma","volume":"3","author":"Watabe","year":"2014","journal-title":"Cancer medicine"},{"key":"10.1016\/j.pan.2018.06.003_bib34","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1038\/sj.onc.1207652","article-title":"Alternative splice variant of actinin-4 in small cell lung cancer","volume":"23","author":"Honda","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.pan.2018.06.003_bib35","first-page":"4695","article-title":"A\u00a0training-testing approach to the molecular classification of resected non-small cell lung cancer","volume":"9","author":"Yamagata","year":"2003","journal-title":"Clin Canc Res Offici J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.pan.2018.06.003_bib36","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/annonc\/mdt293","article-title":"Distinct outcome of stage i lung adenocarcinoma with actn4 cell motility gene amplification","volume":"24","author":"Noro","year":"2013","journal-title":"Ann Oncol Offic. J. Euro. Soc. Medical Oncol. ESMO"},{"key":"10.1016\/j.pan.2018.06.003_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/annonc\/mds215","article-title":"Diagnostic and prognostic significance of the alternatively spliced actn4 variant in high-grade neuroendocrine pulmonary tumours","volume":"24","author":"Miyanaga","year":"2013","journal-title":"Ann Oncol Offic. J. Euro. Soc. Medical Oncol. ESMO"},{"key":"10.1016\/j.pan.2018.06.003_bib38","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/cncr.23110","article-title":"Identification of alpha-actinin 4 and 67 kda laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches","volume":"110","author":"Fu","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.pan.2018.06.003_bib39","first-page":"1278","article-title":"Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type","volume":"20","author":"Yamamoto","year":"2007","journal-title":"Mod Pathol Offic. J. U S Can. Aca. Pathol."},{"key":"10.1016\/j.pan.2018.06.003_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.urology.2009.09.037","article-title":"The role of actinin-4 in bladder cancer invasion","volume":"75","author":"Koizumi","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.pan.2018.06.003_bib41","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3892\/or.2013.2577","article-title":"Increased expression of alpha-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer","volume":"30","author":"Yoshii","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pan.2018.06.003_bib42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/onc.2012.69","article-title":"Mtbp suppresses cell migration and filopodia formation by inhibiting actn4","volume":"32","author":"Agarwal","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.pan.2018.06.003_bib43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10555-012-9364-x","article-title":"Mdm2 binding protein, a novel metastasis suppressor","volume":"31","author":"Iwakuma","year":"2012","journal-title":"Canc Metastasis Rev"},{"key":"10.1016\/j.pan.2018.06.003_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the akt2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"key":"10.1016\/j.pan.2018.06.003_bib45","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"Akt2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pan.2018.06.003_bib46","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.91.6.2156","article-title":"Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization","volume":"91","author":"Kallioniemi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pan.2018.06.003_bib47","first-page":"8235","article-title":"Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers","volume":"11","author":"Kim","year":"2005","journal-title":"Clin Canc Res Offic. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.pan.2018.06.003_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-4-5","article-title":"Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma","volume":"4","author":"Rao","year":"2004","journal-title":"BMC Canc"},{"key":"10.1016\/j.pan.2018.06.003_bib49","first-page":"54","article-title":"Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization","volume":"1994","author":"Ried","year":"1801","journal-title":"Canc Res"},{"key":"10.1016\/j.pan.2018.06.003_bib50","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.84.14.5034","article-title":"Molecular cloning of the akt oncogene and its human homologues akt1 and akt2: amplification of akt1 in a primary human gastric adenocarcinoma","volume":"84","author":"Staal","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pan.2018.06.003_bib51","first-page":"7157","article-title":"Identification of a candidate oncogene sei-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines","volume":"62","author":"Tang","year":"2002","journal-title":"Canc Res"},{"key":"10.1016\/j.pan.2018.06.003_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-4608(95)00248-0","article-title":"Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, fish, and molecular studies","volume":"87","author":"Thompson","year":"1996","journal-title":"Canc Genet Cytogenet"},{"key":"10.1016\/j.pan.2018.06.003_bib53","first-page":"499","article-title":"Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance","volume":"22","author":"Yamamoto","year":"2009","journal-title":"Mod Pathol Offic. J. U S Can. Aca. Pathol."},{"key":"10.1016\/j.pan.2018.06.003_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13578-015-0031-0","article-title":"The biological role of actinin-4 (actn4) in malignant phenotypes of cancer","volume":"5","author":"Honda","year":"2015","journal-title":"Cell Biosci"},{"key":"10.1016\/j.pan.2018.06.003_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10014-013-0139-z","article-title":"Immunohistochemical actinin-4 expression in infiltrating gliomas: association with who grade and differentiation","volume":"31","author":"Fukushima","year":"2014","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.pan.2018.06.003_bib56","first-page":"887","article-title":"The microtubule inhibiting agent epothilone b antagonizes glioma cell motility associated with reorganization of the actin-binding protein alpha-actinin 4","volume":"25","author":"Henry","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pan.2018.06.003_bib57","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.yexcr.2010.02.011","article-title":"Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and rhoa signaling of astrocytoma cells","volume":"316","author":"Quick","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pan.2018.06.003_bib58","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijom.2017.03.001","article-title":"Prognostic significance of gene amplification of actn4 in stage i and ii oral tongue cancer","volume":"46","author":"Kakuya","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.pan.2018.06.003_bib59","first-page":"3157","article-title":"Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer","volume":"34","author":"Tanaka","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pan.2018.06.003_bib60","doi-asserted-by":"crossref","first-page":"33165","DOI":"10.18632\/oncotarget.8890","article-title":"Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with actn4","volume":"7","author":"Miura","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pan.2018.06.003_bib61","first-page":"1663","article-title":"The alternatively spliced actinin-4 variant as a prognostic marker for metastasis in small-cell lung cancer","volume":"35","author":"Okamoto","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pan.2018.06.003_bib62","first-page":"286","article-title":"Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer","volume":"10","author":"Wang","year":"2015","journal-title":"J\u00a0Thorac Oncol Official Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.pan.2018.06.003_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-12-416673-8.00005-8","article-title":"Alpha-actinin 4 and tumorigenesis of breast cancer","volume":"93","author":"Hsu","year":"2013","journal-title":"Vitam Horm"},{"key":"10.1016\/j.pan.2018.06.003_bib64","first-page":"286","article-title":"The actin-binding protein, actinin alpha 4 (actn4), is a nuclear receptor coactivator that promotes proliferation of mcf-7 breast cancer cells","volume":"2011","author":"Khurana","year":"1850","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pan.2018.06.003_bib65","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1365-2559.2011.04163.x","article-title":"Actn4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas","volume":"60","author":"Yamamoto","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pan.2018.06.003_bib66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1074\/mcp.M600169-MCP200","article-title":"Identification of putative androgen receptor interaction protein modules: cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells","volume":"6","author":"Jasavala","year":"2007","journal-title":"Mol Cell Proteomics MCP"},{"key":"10.1016\/j.pan.2018.06.003_bib67","doi-asserted-by":"crossref","first-page":"32717","DOI":"10.1074\/jbc.M114.579185","article-title":"Alpha-actinin-4 is required for amoeboid-type invasiveness of melanoma cells","volume":"289","author":"Shao","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pan.2018.06.003_bib68","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood-2008-10-183483","article-title":"The mll recombinome of adult cd10-negative b-cell precursor acute lymphoblastic leukemia: results from the gmall study group","volume":"113","author":"Burmeister","year":"2009","journal-title":"Blood"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318306082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318306082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:06:49Z","timestamp":1761408409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390318306082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1424390318306082"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2018.06.003","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of copy number of ACTN4 to optimize the therapeutic strategy for locally advanced pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}